Cabral-Marques H - Search Results

1

Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation.

Dogbe MG, Mafilaza AY, Eleutério CV, Cabral-Marques H, Simões S, Gaspar MM. Dogbe MG, et al. Among authors: cabral marques h. Pharmaceutics. 2019 Oct 10;11(10):521. doi: 10.3390/pharmaceutics11100521. Pharmaceutics. 2019. PMID: 31658657 Free PMC article.

2

Preparation and characterization of a synthetic curcumin analog inclusion complex and preliminary evaluation of in vitro antileishmanial activity.

Pinto LMA, Adeoye O, Thomasi SS, Francisco AP, Carvalheiro MC, Cabral-Marques H. Pinto LMA, et al. Among authors: cabral marques h. Int J Pharm. 2020 Nov 15;589:119764. doi: 10.1016/j.ijpharm.2020.119764. Epub 2020 Aug 25. Int J Pharm. 2020. PMID: 32858130

3

The Effect of Lycopene Preexposure on UV-B-Irradiated Human Keratinocytes.

Ascenso A, Pedrosa T, Pinho S, Pinho F, de Oliveira JM, Cabral Marques H, Oliveira H, Simões S, Santos C. Ascenso A, et al. Oxid Med Cell Longev. 2016;2016:8214631. doi: 10.1155/2016/8214631. Epub 2015 Nov 17. Oxid Med Cell Longev. 2016. PMID: 26664697 Free PMC article.

4

Cyclodextrin nanosystems in oral drug delivery: A mini review.

Adeoye O, Cabral-Marques H. Adeoye O, et al. Among authors: cabral marques h. Int J Pharm. 2017 Oct 15;531(2):521-531. doi: 10.1016/j.ijpharm.2017.04.050. Epub 2017 Apr 26. Int J Pharm. 2017. PMID: 28455134 Review.

5

Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity.

Adeoye O, Bártolo I, Conceição J, da Silva AB, Duarte N, Francisco AP, Taveira N, Cabral-Marques H. Adeoye O, et al. Among authors: cabral marques h. Int J Pharm. 2020 Jun 15;583:119356. doi: 10.1016/j.ijpharm.2020.119356. Epub 2020 Apr 20. Int J Pharm. 2020. PMID: 32325245

6

Validation of an HPLC Analytical Method for the Quantitative/Qualitative Determination of Fluticasone Propionate in Inhalation Particles on Several Matrices.

Sá Couto AR, Cardoso DE, Cabral-Marques HM. Sá Couto AR, et al. Sci Pharm. 2014 Jun 16;82(4):787-97. doi: 10.3797/scipharm.1404-11. Print 2014 Oct-Dec. Sci Pharm. 2014. PMID: 26171324 Free PMC article.

7

Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes.

Cabral-Marques H, Almeida R. Cabral-Marques H, et al. Eur J Pharm Biopharm. 2009 Sep;73(1):121-9. doi: 10.1016/j.ejpb.2009.05.002. Epub 2009 May 13. Eur J Pharm Biopharm. 2009. PMID: 19446024

8

Comparison of ibuprofen release from minitablets and capsules containing ibuprofen: β-cyclodextrin complex.

Salústio PJ, Cabral-Marques HM, Costa PC, Pinto JF. Salústio PJ, et al. Eur J Pharm Biopharm. 2011 May;78(1):58-66. doi: 10.1016/j.ejpb.2010.12.022. Epub 2010 Dec 30. Eur J Pharm Biopharm. 2011. PMID: 21195175

9

The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.

Salústio PJ, Feio G, Figueirinhas JL, Pinto JF, Cabral Marques HM. Salústio PJ, et al. Eur J Pharm Biopharm. 2009 Feb;71(2):377-86. doi: 10.1016/j.ejpb.2008.09.027. Epub 2008 Oct 17. Eur J Pharm Biopharm. 2009. PMID: 18977436

10

Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: In silico prediction; Effects of derivatization, molar ratio and preparation method.

Adeoye O, Conceição J, Serra PA, Bento da Silva A, Duarte N, Guedes RC, Corvo MC, Aguiar-Ricardo A, Jicsinszky L, Casimiro T, Cabral-Marques H. Adeoye O, et al. Among authors: cabral marques h. Carbohydr Polym. 2020 Jan 1;227:115287. doi: 10.1016/j.carbpol.2019.115287. Epub 2019 Sep 6. Carbohydr Polym. 2020. PMID: 31590843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page